MetaCap

LENSAR (LNSR) vs SkyAI (SKYA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

LENSAR (LNSR) has outperformed SkyAI (SKYA) over the past year, losing 47.0% versus a loss of 74.7%. LENSAR is the larger company by market cap ($79.2 million vs $73.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LNSR-47.04%SKYA-74.74%
+9%-41%-90%
Oct 8, 20251 yearOct 8, 2026
LNSR-13.19%SKYA-99.99%
+114%+2%-110%
Apr 11, 20225 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LNSR versus SKYA key metrics
MetricLNSRSKYA
Share price$6.45$1.69
Market cap$79.24M$73.09M
1-day change-0.92%-6.63%
YTD return-44.54%-16.75%
1-year return-47.04%-74.74%
5-year return-14.23%—
P/E ratio (TTM)35.83—
EPS (TTM)$0.18$-4.73
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$12.94$6.75
52-week low$4.95$0.91
Distance from 52-week high-50.15%-74.96%
Analyst consensusstrong_buy—
Avg. price target upside+75.66%—
Average volume102.04K318.14K
Shares outstanding12.29M43.25M
Employees15030
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LNSR has outperformed SKYA by 27.7 percentage points over the past year.

About LENSAR

LNSR stock →

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.

Health Care · Medical/Dental Instruments · 150 employees

About SkyAI

SKYA stock →

SkyAI, Inc. engages in building an Agentic finance for the global south.

Health Care · Medical/Dental Instruments · 30 employees

LNSR vs SKYA FAQ

Which is bigger, LENSAR or SkyAI?

LENSAR (LNSR) is larger, with a market capitalization of $79.24M compared with $73.09M for SkyAI (SKYA).

Which stock has performed better over the past year, LNSR or SKYA?

LNSR returned -47.04% over the past 12 months, compared with -74.74% for SKYA (price return, excluding dividends). Past performance does not predict future results.

Are LENSAR and SkyAI in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons